Open AccessCase report: thermal helium in the treatment of coronavirus pneumonia caused by new coronavirus infection COVID-19 (SARS-CoV-2)
Author(s) -
S. V. Zhuravel,
Pavel Gavrilov,
Kuznetsova Na,
И. И. Уткина,
А. М. Талызин,
В. Э. Александрова
Publication year - 2021
Publication title -
vestnik medicinskogo instituta «reaviz». reabilitaciâ, vrač i zdorovʹe/vestnik medicinskogo instituta "reaviz". reabilitaciâ, vrač i zdorovʹe
Language(s) - English
Resource type - Journals
eISSN - 2782-1579
pISSN - 2226-762X
DOI - 10.20340/vmi-rvz.2021.1.covid.1
Subject(s) - covid-19 , coronavirus , pneumonia , medicine , helium , outbreak , inert gas , virology , chemistry , disease , infectious disease (medical specialty) , organic chemistry
The novel SARS-CoV-2 coronavirus, which originated in December 2019 in Wuhan, China, has triggered an outbreak of a respiratory illness called COVID-19. Helium is a colorless inert gas, odorless and tasteless. Thermal helium-oxygen therapy is a new and innovative method that allows you to maintain the diffusion capacity of the lungs. The clinical case presented in this article shows that inhalation of a thermal gas mixture of helium and oxygen (t-He/O2) in the standard therapy of a patient with pneumonia caused by SARS-CoV-2 positively influenced the clinical picture of the disease, improves gas exchange, and promotes accelerating the elimination of the virus, rehabilitation and discharge of the patient.